Nuclear transfer to prevent mitochondrial DNA disorders: revisiting the debate on reproductive cloning

Abstract Preclinical experiments are currently performed to examine the feasibility of several types of nuclear transfer to prevent mitochondrial DNA (mtDNA) disorders. Whereas the two most promising types of nuclear transfer to prevent mtDNA disorders, spindle transfer and pronuclear transfer, do n...

Full description

Saved in:
Bibliographic Details
Published in:Reproductive biomedicine online 2011-02, Vol.22 (2), p.200-207
Main Authors: Bredenoord, A.L, Dondorp, W, Pennings, G, De Wert, G
Format: Article
Language:English
Subjects:
Blastomeres - transplantation
Cloning, Organism - ethics
Cloning, Organism - methods
ethics
Humans
Mitochondrial Diseases - prevention & control
mitochondrial DNA disorders
nuclear transfer
Nuclear Transfer Techniques - ethics
Obstetrics and Gynecology
reproductive cloning
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Preclinical experiments are currently performed to examine the feasibility of several types of nuclear transfer to prevent mitochondrial DNA (mtDNA) disorders. Whereas the two most promising types of nuclear transfer to prevent mtDNA disorders, spindle transfer and pronuclear transfer, do not amount to reproductive cloning, one theoretical variant, blastomere transfer does. This seems the most challenging both technically and ethically. It is prohibited by many jurisdictions and also the scientific community seems to avoid it. Nevertheless, this paper examines the moral acceptability of blastomere transfer as a method to prevent mtDNA disorders. The reason for doing so is that most objections against reproductive cloning refer to reproductive adult cloning, while blastomere transfer would amount to reproductive embryo cloning. After clarifying this conceptual difference, this paper examines whether the main non-safety objections brought forward against reproductive cloning also apply in the context of blastomere transfer. The conclusion is that if this variant were to become safe and effective, dismissing it because it would involve reproductive cloning is unjustified. Nevertheless, as it may lead to more complex ethical appraisals than the other variants, researchers should initially focus on the development of the other types of nuclear transfer to prevent mtDNA disorders. Mitochondrial DNA (mtDNA) disorders are usually severe disorders. Patients show a wide variety of symptoms, including deafness, blindness, diabetes, loss of skills and heart and liver failure. As there is no curative treatment, helping carriers of mtDNA mutations to have healthy children has been a central focus of attention. One reproductive option currently in development is nuclear transfer, in which faulty mitochondria are replaced with healthy ones. This should result in healthy offspring with the nuclear genes of the parents, but without the mtDNA mutation. Whereas the two most promising types of nuclear transfer to prevent mtDNA disorders do not amount to reproductive cloning, one theoretical variant would. This type seems the most challenging variant both technically and ethically. Most objections against reproductive cloning refer to reproductive adult cloning, while this variant would amount to reproductive embryo cloning. In this paper, we examine the moral acceptability of this variant as a method to prevent mtDNA disorders and whether and to what extent the main n
ISSN:1472-6483
1472-6491
DOI:10.1016/j.rbmo.2010.10.016